Professor Sir Alimuddin Zumla

Dikutip oleh

	Semua	Sejak 2020
Kutipan	91531	51221
indeks-h	145	106
indeks-i10	689	495

11000

5500

2750

8250

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025233 246 362 458 649 803 845 1024 1224 1634 1991 2697 3445 4499 5035 4623 4158 4244 10407 10711 9524 8498 10004 1800

Akses publik

Lihat semua

456 artikel

17 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Markus MaeurerChampalimaud Foundation, Lisbon Portugal and I Medical Clinical, University of Mainz, GermanyEmail yang diverifikasi di fundacaochampalimaud.pt
Giuseppe IppolitoScientific Director - INMI- National Institute for Infectious Diseases Lazzaro Spllanzani Email yang diverifikasi di inmi.it
Matthew BatesUniversity of LincolnEmail yang diverifikasi di lincoln.ac.uk
David HuiChinese University of Hong KongEmail yang diverifikasi di cuhk.edu.hk
Esam Ibraheem AzharSpecial Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz UniversityEmail yang diverifikasi di kau.edu.sa
Keertan DhedaProfessor, University of Cape Town & London School of Hygiene and Tropical MedicineEmail yang diverifikasi di uct.ac.za
nathan kapataInfectious Diseases and Public Health Specialist, Ministry of HealthEmail yang diverifikasi di AmsterdamUMC.nl
Graham RookUCL (University College London)Email yang diverifikasi di ucl.ac.uk
Jim F HuggettNational Measurement Laboratory/University of SurreyEmail yang diverifikasi di lgcgroup.com
Richard KockProfessor Wildlife Health and Emerging DiseasesEmail yang diverifikasi di rvc.ac.uk
Timothy D. McHughProfessor of Medical Microbiology, UCLEmail yang diverifikasi di ucl.ac.uk
Michael HoelscherDirektor Tropenmedizin, Klinikum der LMUEmail yang diverifikasi di lrz.uni-muenchen.de
Ben MaraisUniversity of SydneyEmail yang diverifikasi di sydney.edu.au
Mario RaviglioneProfessor of Global Health, University of Milan, ItalyEmail yang diverifikasi di unimi.it
Najmul HaiderLecturer, Keele University, the United KingdomEmail yang diverifikasi di keele.ac.uk
Ibrahim AbubakarUniversity College LondonEmail yang diverifikasi di ucl.ac.uk
Simon TiberiGSK Global Health Physician, Honorary Professor, Queen Mary University of LondonEmail yang diverifikasi di qmul.ac.uk
Christian DrostenDirector, Institute of Virology, Charite Universitätsmedizin BerlinEmail yang diverifikasi di charite.de
Marco SchitoScientific DirectorEmail yang diverifikasi di c-path.org
Abdullah M AssiriMinistry of Health Saudi ArabiaEmail yang diverifikasi di moh.gov.sa

Ikuti

Professor Sir Alimuddin Zumla

University College London

Email yang diverifikasi di ucl.ac.uk - Beranda

1.Respiratory tract infections(TB TB-HIV CAP)2) Emerging and Re-Emerging infections with epidemic potential inc Coronaviruse


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China PE Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh ... International Journal of Infectious Diseases 91 (10.1016/j.ijid.2020.01.009 …, 2020	4290	2020
Real-time RT-PCR normalisation; strategies and considerations J Huggett, K Dheda, S Bustin, A Zumla Genes & Immunity 6 (4), 279-284, 2005	2505	2005
Coronaviruses—drug discovery and therapeutic options A Zumla, JFW Chan, EI Azhar, DSC Hui, KY Yuen Nature reviews Drug discovery 15 (5), 327-347, 2016	2080	2016
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study A Assiri, JA Al-Tawfiq, AA Al-Rabeeah, FA Al-Rabiah, S Al-Hajjar, ... The Lancet infectious diseases 13 (9), 752-761, 2013	1836	2013
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023	1801	2023
Hospital outbreak of Middle East respiratory syndrome coronavirus A Assiri, A McGeer, TM Perl, CS Price, AA Al Rabeeah, DAT Cummings, ... New England Journal of Medicine 369 (5), 407-416, 2013	1570	2013
Middle East respiratory syndrome A Zumla, DS Hui, S Perlman The Lancet 386 (9997), 995-1007, 2015	1548	2015
Validation of housekeeping genes for normalizing RNA expression in real-time PCR K Dheda, JF Huggett, SA Bustin, MA Johnson, G Rook, A Zumla Biotechniques 37 (1), 112-119, 2004	1349	2004
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022	1207	2022
Advances in the development of new tuberculosis drugs and treatment regimens A Zumla, P Nahid, ST Cole Nature reviews Drug discovery 12 (5), 388-404, 2013	1196	2013
Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts J Chakaya, M Khan, F Ntoumi, E Aklillu, R Fatima, P Mwaba, N Kapata, ... International journal of infectious diseases 113, S7-S12, 2021	1105	2021
Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention E Petersen, A Kantele, M Koopmans, D Asogun, A Yinka-Ogunleye, ... Infectious Disease Clinics 33 (4), 1027-1043, 2019	811	2019
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis JA Caminero, G Sotgiu, A Zumla, GB Migliori The Lancet infectious diseases 10 (9), 621-629, 2010	785	2010
Manson's Tropical Diseases G Cook, A Zumla Harcourt Brace Saunders Publishing Group, London 21, 1,0847, 2003	783*	2003
Severe acute respiratory syndrome: historical, epidemiologic, and clinical features DSC Hui, A Zumla Infectious Disease Clinics 33 (4), 869-889, 2019	765	2019
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization K Dheda, JF Huggett, JS Chang, LU Kim, SA Bustin, MA Johnson, ... Analytical biochemistry 344 (1), 141-143, 2005	762	2005
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis NAJ Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR ... N Engl J Med 17 (371), 1577-1587, 2014	743*	2014
Family cluster of Middle East respiratory syndrome coronavirus infections ZA Memish, AI Zumla, RF Al-Hakeem, AA Al-Rabeeah, GM Stephens New England Journal of Medicine 368 (26), 2487-2494, 2013	673	2013
Immunological biomarkers of tuberculosis G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla Nature Reviews Immunology 11 (5), 343-354, 2011	653	2011
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice RS Wallis, M Pai, D Menzies, TM Doherty, G Walzl, MD Perkins, A Zumla The lancet 375 (9729), 1920-1937, 2010	644	2010

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama